Literature DB >> 30740416

Therapeutic strategies for type 2 diabetes mellitus patients with very high HbA1c: is insulin the only option?

Muhammad Abdul-Ghani1, Ralph DeFronzo1.   

Abstract

Entities:  

Year:  2018        PMID： 30740416      PMCID： PMC6330628          DOI： 10.21037/atm.2018.11.15

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  29 in total

Review 1.  Microvascular complications of diabetes.

Authors:  Zhiheng He; George L King
Journal:  Endocrinol Metab Clin North Am       Date:  2004-03       Impact factor: 4.741

2.  Is glycemic control improving in U.S. adults?

Authors:  Thomas J Hoerger; Joel E Segel; Edward W Gregg; Jinan B Saaddine
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

3.  Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.

Authors:  M A Abdul-Ghani; C Puckett; C Triplitt; D Maggs; J Adams; E Cersosimo; R A DeFronzo
Journal:  Diabetes Obes Metab       Date:  2015-01-07       Impact factor: 6.577

4.  Longitudinal effects of medication nonadherence on glycemic control.

Authors:  Leonard E Egede; Mulugeta Gebregziabher; Carrae Echols; Cheryl P Lynch
Journal:  Ann Pharmacother       Date:  2014-02-28       Impact factor: 3.154

5.  Achievement of goals in U.S. diabetes care, 1999-2010.

Authors:  Mohammed K Ali; Kai McKeever Bullard; Jinan B Saaddine; Catherine C Cowie; Giuseppina Imperatore; Edward W Gregg
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

6.  Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

Authors:  Bernard M Y Cheung; Kwok Leung Ong; Stacey S Cherny; Pak-Chung Sham; Annette W K Tso; Karen S L Lam
Journal:  Am J Med       Date:  2009-05       Impact factor: 4.965

7.  The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.

Authors:  Annette M Chang; Grethe Jakobsen; Jeppe Sturis; Marla J Smith; Cathie J Bloem; Bob An; Andrzej Galecki; Jeffrey B Halter
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

8.  Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.

Authors:  Mathijs C Bunck; Anja Cornér; Bjorn Eliasson; Robert J Heine; Rimma M Shaginian; Marja-Riitta Taskinen; Ulf Smith; Hannele Yki-Järvinen; Michaela Diamant
Journal:  Diabetes Care       Date:  2011-09       Impact factor: 19.112

9.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Authors:  Caroline S Fox; Kunihiro Matsushita; Mark Woodward; Henk J G Bilo; John Chalmers; Hiddo J Lambers Heerspink; Brian J Lee; Robert M Perkins; Peter Rossing; Toshimi Sairenchi; Marcello Tonelli; Joseph A Vassalotti; Kazumasa Yamagishi; Josef Coresh; Paul E de Jong; Chi-Pang Wen; Robert G Nelson
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.